Skip to content

Medifast MED Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin71.3%-2.5pp73.8%+1.4pp72.4%+1.0pp71.3%-2.5pp
Operating margin-3.7%-4.2pp0.5%-11.3pp11.8%+0.2pp11.6%-2.6pp
Net margin-4.8%-5.2pp0.3%-8.9pp9.3%+0.3pp9%-1.8pp
EBITDA margin0%-2.6pp2.6%-10.4pp13%+0.8pp12.2%-2.4pp
Returns
Return on equity-9.1%-10.1pp1%-54.8pp55.8%-24.5pp80.3%-10.9pp
Return on assets-7%-7.7pp0.7%-31.1pp31.8%-8.4pp40.2%-8.5pp
Return on invested capital-11.1%-12.3pp1.2%-86.5pp87.7%-40.9pp128.6%-114pp
Efficiency
Asset turnover1.4×-0.6×-1.4×3.4×-1.1×4.5×-0.1×
Inventory turnover3.5×+0.3×3.3×-0.2×3.4×+0.3×3.1×-0.3×
Liquidity
Current ratio4.7×+1.4×3.3×+0.9×2.4×+0.8×1.6×-0.2×
Quick ratio4.2×+1.5×2.7×+0.8×1.8×+1.1×0.7×0.0×
Cash ratio2.1×+0.7×1.4×+0.4×+0.4×0.6×0.0×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×-0.1×0.2×0.0×
Debt-to-assets0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-2,620.3×-2,616×-4.8×-4.3×-0.5×-0.2×-0.3×0.0×
Interest coverage-2.6×-3.2×0.6×-50.2×50.8×
Per Share
Book value per share$18.11-5.5%$19.17+3.9%$18.45+34.2%$13.75-19.8%
Valuation
Market capitalization$121.87M-17.4%$192.72M-73.7%$732.23M-41.9%$1.26B-48.2%
Enterprise value$66.44M+12.8%$117.92M-82.1%$659.8M-45.0%$1.2B-49.2%
Price / sales0.4×0.0×0.3×-0.4×0.7×-0.1×0.8×-0.8×
Price / book0.6×-0.1×0.9×-2.7×3.6×-4.5×8.1×-3.9×
EV / EBITDA1,292.6×+1,285×7.6×+2.8×4.7×-1.4×6.1×-4.5×
EV / sales0.2×+0.1×0.2×-0.4×0.6×-0.1×0.7×-0.8×
Earnings yield-16.4%-18.9pp1.1%-12.5pp13.6%+2.2pp11.4%+4.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Medifast's profit margins?
Medifast (MED) runs a 70.1% gross margin and a -4.7% operating margin, with a -5.8% net margin.
Where do Medifast's ratios come from?
Every ratio is computed from Medifast's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.